Loading...
Based on the provided data, cbdMD Inc (YCBD) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive financial performance, absence of significant trading trends, no recent news or catalysts, and no strong proprietary trading signals suggest that holding off on this stock is a better decision at this time.
The MACD is positive and expanding (0.0306), indicating a slight bullish momentum. RSI is neutral at 68.793, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level (0.872), with resistance at 1.025 and support at 0.719. Overall, the technical indicators suggest a neutral to slightly bullish trend but lack strong conviction.
NULL identified. No recent news, trading trends, or significant events to act as positive catalysts.
Financial performance is weak, with revenue, net income, EPS, and gross margin all declining YoY in the latest quarter (2026/Q1). No significant hedge fund or insider activity, and no recent congress trading data.
In 2026/Q1, revenue dropped by -1.89% YoY to $5,016,904. Net income and EPS both dropped by -100% YoY, indicating significant financial struggles. Gross margin also declined slightly by -1.42% YoY to 59.82%. Overall, the company is showing poor financial performance.
No data available for analyst ratings or price target changes.